White House Releases Executive Orders Aimed at Addressing High Drug Prices

September 14, 2020

President Trump yesterday signed an additional executive order aimed at lowering the price of prescription drugs. Three executive orders were signed in July seeking to do the same. Yesterday’s order directs the Secretary of Health and Human Services (HHS) to test a “most-favored-nation” pricing model for Part B, and some Part D, drugs. View highlights under key resources. 

 

Sign In to Download the Special Bulletin:
White House Releases Executive Orders Aimed at Addressing High Drug Prices

Related Resources

Letter/Comment
AHA Comments on CMS Proposed Medicare Drug Pricing Model
Public
Advisory
CMS Finalizes Guidance on Implementation of the Medicare Drug Price Negotiation Program
Member
Letter/Comment
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
Public
Infographics
Drug Prices and Shortages Increase Hospitals’ Costs and Jeopardize Patient Access to Care Infographic
AHA Center for Health Innovation Market Scan
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future
Guides/Reports
Costs of Caring
Public